| |
| |
|
| Insider
Information: |
Baker Mark Robert |
| Relationship: |
CEO, Director |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
161,141 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$660,678 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
161,141 |
|
|
| Total
Value |
$660,678 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progenics Pharmaceuticals Inc |
PGNX |
CEO, Director |
2013-03-27 |
161,141 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2012-11-16 |
4 |
B |
$1.82 |
$90,723 |
D/D |
49,793 |
143,465 |
2.81 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2012-11-15 |
4 |
B |
$1.69 |
$82,332 |
D/D |
48,833 |
93,672 |
2.81 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2011-07-01 |
4 |
OE |
$5.46 |
$109,375 |
D/D |
20,032 |
52,254 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2010-10-01 |
4 |
OE |
$4.32 |
$75,759 |
D/D |
17,545 |
45,158 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2011-07-01 |
4 |
D |
$7.40 |
$125,097 |
D/D |
(16,905) |
35,349 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2010-10-01 |
4 |
D |
$5.08 |
$81,138 |
D/D |
(15,972) |
29,186 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2007-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
13,333 |
24,398 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2012-11-19 |
4 |
B |
$1.96 |
$23,104 |
D/D |
11,800 |
155,265 |
2.81 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2006-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
10,738 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2008-07-01 |
4 |
OE |
$13.64 |
$66,359 |
D/D |
4,865 |
30,352 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2010-01-04 |
4 |
OE |
$3.78 |
$17,856 |
D/D |
4,720 |
34,883 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2010-07-01 |
4 |
OE |
$4.44 |
$20,313 |
D/D |
4,575 |
31,503 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2008-07-01 |
4 |
D |
$16.05 |
$71,053 |
D/D |
(4,427) |
25,925 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2011-01-03 |
4 |
OE |
$4.83 |
$21,132 |
D/D |
4,377 |
33,765 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2010-01-04 |
4 |
D |
$4.45 |
$19,113 |
D/D |
(4,295) |
30,588 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2010-07-01 |
4 |
D |
$5.35 |
$21,978 |
D/D |
(4,108) |
27,395 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2011-04-01 |
4 |
OE |
$5.05 |
$20,311 |
D/D |
4,022 |
34,017 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2011-01-03 |
4 |
D |
$5.68 |
$22,800 |
D/D |
(4,014) |
29,751 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2009-10-01 |
4 |
OE |
$4.26 |
$17,032 |
D/D |
3,999 |
33,554 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2009-10-01 |
4 |
D |
$5.01 |
$18,231 |
D/D |
(3,639) |
29,915 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2011-04-01 |
4 |
D |
$6.29 |
$22,330 |
D/D |
(3,550) |
30,467 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2007-07-02 |
4 |
OE |
$18.71 |
$64,568 |
D/D |
3,451 |
27,900 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2009-04-01 |
4 |
OE |
$5.65 |
$17,967 |
D/D |
3,180 |
27,942 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2007-07-02 |
4 |
D |
$22.01 |
$69,111 |
D/D |
(3,140) |
24,760 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2006-07-03 |
4 |
OE |
$25.01 |
$76,431 |
D/D |
3,056 |
5,506 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
